Common mistakes with LL-37
Avoid the most common pitfalls when working with LL-37 in a research setting: storage, reconstitution, concentration, and COA verification mistakes.
Mistake 1: Improper storage after reconstitution
Once LL-37 is reconstituted with bacteriostatic water, it must be stored at 2-8°C (refrigerated) and used within 28 days. A common mistake is leaving the vial at room temperature for extended periods, which degrades the peptide and can invalidate experimental results.
Freeze-thaw cycles are another issue — each cycle reduces peptide integrity. If your protocol requires long-term storage, keep the lyophilised vial frozen at -20°C until the moment of reconstitution.
Mistake 2: Concentration miscalculation
Calculating the target concentration wrong is one of the most common experimental errors with LL-37. Always double-check:
- The stated vial mass (e.g. 5mg, 10mg)
- The volume of bacteriostatic water added
- The resulting concentration (mass / volume)
- The volume of reconstituted solution you draw into the syringe for each dose point
A simple spreadsheet or lab notebook with these values at the top of every experiment can prevent costly errors.
Mistake 3: Skipping COA verification
Researchers sometimes trust a supplier's purity claim without checking the actual COA. For LL-37, always:
- Match the batch number on your vial to the COA on the product page
- Verify the HPLC chromatogram shows a single clean peak
- Confirm the mass spectrometry reading matches the theoretical molecular weight
- Check the expiry date
Skipping this step means you are treating purity as a marketing claim rather than a verifiable fact. Peptify publishes every batch COA at peptifyuk.com, downloadable directly from each product page.
Buy LL-37 for research
99%+ HPLC-verified LL-37 in stock. Every vial ships from the UK with a batch-specific Certificate of Analysis. Same-day dispatch on orders before 1pm.
Frequently asked questions
What is LL-37?
LL-37 is the only cathelicidin-derived antimicrobial peptide found in humans. It is studied in the antimicrobial, immune-modulation, and epithelial-barrier research literature.
What is LL-37 researched for?
Published preclinical research has examined LL-37 in antimicrobial-pathway, immune-signalling, and epithelial-barrier studies. It is one of the most-studied endogenous host-defence peptides in the in-vitro literature.
What purity does Peptify LL-37 meet?
Peptify LL-37 is 99%+ HPLC-verified with a batch-specific Janoshik Analytical Certificate of Analysis downloadable from the product page.